Lo JE, Freitag SK, Liu CY, Barbesino G, et al. Long-term Cardiovascular, Renal, and Safety Outcomes of Teprotumumab versus Systemic Glucocorticoids in Thyroid Eye Disease: A Target Trial Emulation. Ophthalmology 2025;132:1142-1151.
PMID: 40398692